NCT00225485View on ClinicalTrials.gov

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 2003

Conditions

Depression

Interventions

DRUG

Effexor XR

Trial Locations (37)

272-0034

Ichikawa

272-0827

Ichikawa

816-0801

Kasuga

802-8533

Kitakyushu

816-0943

Ohnojo

731-0121

Hiroshima

047-0032

Otaru

003-0804

Sapporo

005-0004

Sapporo

005-0842

Sapporo

006-8555

Sapporo

011-0022

Sapporo

060-0007

Sapporo

063-0804

Sapporo

064-0915

Sapporo

065-0027

Sapporo

305-8576

Tsukuba

025-0033

Hanamaki

211-0063

Kawasaki

213-8507

Kawasaki

228-0803

Sagamihara

224-8503

Yokohama

227-8501

Yokohama

700-8558

Okayama

570-8506

Moriguchi

590-0018

Sakai

589-0011

Sayama

589-8511

Sayama

120-0033

Adachi-ku

101-8643

Chiyoda-ku

183-8524

Fuchū

189-0012

Higashimurayama

187-8551

Kodaira

152-0012

Meguro-ku

164-0003

Nakano-ku

154-0004

Setagaya-ku

190-0012

Tachikawa

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00225485 - Study Evaluating Effexor XR in Elderly Patients With Major Depression. | Biotech Hunter | Biotech Hunter